Neonatal Status Epilepticus

Seminars in Pediatric Neurology

Volumn 17, Issue 3, 2010, Pages 163-168

  Lawrence, Russell ^a   Inder, Terrie ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Cook Children's Hospital ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUMETANIDE; ETIRACETAM; LIDOCAINE; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE;

BRAIN ISCHEMIA; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DISEASE PREDISPOSITION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; EPILEPTOGENESIS; HIGH RISK POPULATION; HUMAN; NERVE CELL DIFFERENTIATION; NERVE CELL EXCITABILITY; NEWBORN; NEWBORN PERIOD; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; REVIEW; SEIZURE;

EID: 77955800407     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spen.2010.06.010     Document Type: Review

References (52)

1. Volpe J.J. Neurology of the Newborn 2008, Elsevier, Philadelphia, PA. (ed 5).
2. Ronen G.M., Penney S., Andrews W. The epidemiology of clinical neonatal seizures in Newfoundland: a population-based study. J Pediatr 1999, 134:71-75.
3. Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA 1993, 270:854-859.
4. Berg A.T., Shinnar S., Levy S.R., et al. Status epilepticus in children with newly diagnosed epilepsy. Ann Neurol 1999, 45:618-623.
5. Silverstein F.S., Jensen F.E. Neonatal seizures. Ann Neurol 2007, 62:112-120.
6. Insel T.R., Miller L.P., Gelhard R.E. The ontogeny of excitatory amino acid receptors in rat forebrain-I. N-methyl-D-aspartate and quisqualate receptors. Neuroscience 1990, 35:31-43.
7. McDonald J.W., Trescher W.H., Johnston M.V. Susceptibility of brain to AMPA induced excitotoxicity transiently peaks during early postnatal development. Brain Res 1992, 583:54-70.
8. Zhong J., Carrozza D.P., Williams K., et al. Expression of mRNAs encoding subunits of the NMDA receptor in developing rat brain. J Neurochem 1995, 64:531-539.
9. Monyer H., Burnashev N., Laurie D.J., et al. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1994, 12:529-540.
10. Burnashev N., Monyer H., Seeburg P.H., et al. Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron 1992, 8:189-198.
11. Jonas P., Racca C., Sakmann B., et al. Differences in Ca2+ permeability of AMPA-type glutamate receptor channels in neocortical neurons caused by differential GluR-B subunit expression. Neuron 1994, 12:1281-1289.
12. Swann J.W., Brady R.J., Martin D.L. Postnatal development of GABA-mediated synaptic inhibition in rat hippocampus. Neuroscience 1989, 28:551-561.
13. Dunning D.D., Hoover C.L., Soltesz I., et al. GABA(A) receptor-mediated miniature postsynaptic currents and alpha-subunit expression in developing cortical neurons. J Neurophysiol 1999, 82:3286-3297.
14. Khazipov R., Khalilov I., Tyzio R., et al. Developmental changes in GABAergic actions and seizure susceptibility in the rat hippocampus. Eur J Neurosci 2004, 19:590-600.
15. Owens D.F., Boyce L.H., Davis M.B., et al. Excitatory GABA responses in embryonic and neonatal cortical slices demonstrated by gramicidin perforated-patch recordings and calcium imaging. J Neurosci 1996, 16:6414-6423.
16. Dzhala V.I., Talos D.M., Sdrulla D.A., et al. NKCC1 transporter facilitates seizures in the developing brain. Nat Med 2005, 11:1205-1213.
17. Murray D.M., Boylan G.B., Ali I., et al. Defining the gap between electrographic seizure burden, clinical expression, and staff recognition of neonatal seizures. Arch Dis Child Fetal Neonatal Ed 2008, 93:187-191.
18. Lawrence R., Mathur A., Nguyen T.H., et al. A pilot study of continuous limited-channel aEEG in term infants with encephalopathy. J Pediatr 2009, 154:835-841.
19. Mathur A.M., Morris L.D., Teteh F., et al. Utility of prolonged bedside amplitude-integrated encephalogram in encephalopathic infants. Am J Perinatol 2008, 25:611-615.
20. Bittigau P., Sifringer M., Genz K., et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A 2002, 99:15089-15094.
21. Sulzbacher S., Farwell J.R., Temkin N., et al. Late cognitive effects of early treatment with phenobarbital. Clin Pediatr (Phila) 1999, 38:387-394.
22. Toet M.C., van der Meij W., de Vries L.S., et al. Comparison between simultaneously recorded amplitude integrated electroencephalogram (cerebral function monitor) and standard electroencephalogram in neonates. Pediatrics 2002, 109:772-779.
23. Shah D.K., Mackay M.T., Lavery S., et al. Accuracy of bedside electroencephalographic monitoring in comparison with simultaneous continuous conventional electroencephalography for seizure detection in term infants. Pediatrics 2008, 121:1146-1154.
24. Sankar R., Painter M.J. Neonatal seizures: After all these years we still love what doesn't work. Neurology 2005, 64:776-777.
25. Bartha A.I., Shen J., Katz K.H., et al. Neonatal seizures: Multicenter variability in current treatment practices. Pediatr Neurol 2007, 37:85-90.
26. Wheless J.W., Clarke D.F., Arzimanoglou A., et al. Treatment of pediatric epilepsy: European expert opinion. Epileptic Disord 2007, 9:353-412.
27. Boylan G.B., Rennie J.M., Pressler R.M., et al. Phenobarbitone, neonatal seizures, and video-EEG. Arch Dis Child Fetal Neonatal Ed 2002, 86:F165-F170.
28. Painter M.J., Scher M.S., Stein A.D., et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med 1999, 341:485-489.
29. Shany E., Benzaqen O., Watemberg N. Comparison of continuous drip of midazolam or lidocaine in the treatment of intractable neonatal seizures. J Child Neurol 2007, 22:255-259.
30. Boylan G.B., Rennie J.M., Chorley G., et al. Second-line anticonvulsant treatment of neonatal seizures: A video-EEG monitoring study. Neurology 2004, 62:486-488.
31. Shoemaker M.T., Rotenberg J.S. Levetiracetam for the treatment of neonatal seizures. J Child Neurol 2007, 22:95-98.
32. Silverstein F.S., Ferriero D.M. Off-label use of antiepileptic drugs for the treatment of neonatal seizures. Pediatr Neurol 2008, 39:77-79.
33. Kim J.S., Kondratyev A., Tomita Y., et al. Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain. Epilepsia 2007, 48:19-26.
34. Koh S., Tibayan F.D., Simpson J.N., et al. NBQX or topiramate treatment after perinatal hypoxia-induced seizures prevents later increases in seizure-induced neuronal injury. Epilepsia 2004, 45:569-575.
35. Schubert S., Brandl U., Brodhun M., et al. Neuroprotective effects of topiramate after hypoxia-ischemia in newborn piglets. Brain Res 2005, 1058:129-136.
36. Sfaello I., Baud O., Arzimanoglou A., et al. Topiramate prevents excitotoxic damage in the newborn rodent brain. Neurobiol Dis 2005, 20:837-848.
37. Dzhala V.I., Brumback A.C., Staley K.J. Bumetanide enhances phenobarbital efficacy in a neonatal seizure model. Ann Neurol 2008, 63:222-235.
38. Kahle K.T., Staley K.J. The bumetanide-sensitive Na-K-2Cl cotransporter NKCC1 as a potential target of a novel mechanism-based treatment strategy for neonatal seizures. Neurosurg Focus 2008, 25:E22.
39. Vanhatalo S., Hellstrom-Westas L., De Vries L.S. Bumetanide for neonatal seizures: Based on evidence or enthusiasm?. Epilepsia 2009, 50:1292-1293.
40. Ben-Ari Y., Holmes G.L. Effects of seizures on developmental processes in the immature brain. Lancet Neurol 2006, 5:1055-1063.
41. Wirrell E.C., Armstrong E.A., Osman L.D., et al. Prolonged seizures exacerbate perinatal hypoxic-ischemic brain damage. Pediatr Res 2001, 50:445-454.
42. Liu Z., Gatt A., Werner S.J., et al. Long-term behavioral deficits following pilocarpine seizures in immature rats. Epilepsy Res 1994, 19:191-204.
43. Sayin U., Sutula T.P., Stafstrom C.E. Seizures in the developing brain cause adverse long-term effects on spatial learning and anxiety. Epilepsia 2004, 45:1539-1548.
44. Holmes G.L., Ben-Ari Y. Seizures in the developing brain: perhaps not so benign after all. Neuron 1998, 21:1231-1234.
45. Holmes G.L. Effects of early seizures on later behavior and epileptogenicity. Ment Retard Dev Disabil Res Rev 2004, 10:101-105.
46. Younkin D.P., Delivoria-Papadopoulos M., Maris J., et al. Cerebral metabolic effects of neonatal seizures measured with in vivo 31P NMR spectroscopy. Ann Neurol 1986, 20:513-519.
47. McBride M.C., Laroia N., Guillet R. Electrographic seizures in neonates correlate with poor neurodevelopmental outcome. Neurology 2000, 55:506-513.
48. Miller S.P., Weiss J., Barnwell A., et al. Seizure-associated brain injury in term newborns with perinatal asphyxia. Neurology 2002, 58:542-548.
49. Glass H., Glidden D., Jeremy R.J., et al. Clinical neonatal seizures are independently associated with outcomes in infants at risk for hypoxic ischemic injury. J Pediatr 2009, 155:318-323.
50. Toet M.C., Groenendaal F., Osredkar D., et al. Postneonatal epilepsy following amplitude-integrated EEG-detected neonatal seizures. Pediatr Neurol 2005, 32:241-247.
51. Brunquell P.J., Glennon C.M., DiMario F.J., et al. Prediction of outcome based on clinical seizure type in newborn infants. J Pediatr 2002, 140:707-712.
52. Hall R.T., Hall F.K., Daily D.K. High-dose phenobarbital therapy in term newborn infants with severe perinatal asphyxia: A randomized, prospective study with three-year follow-up. J Pediatr 1998, 132:345-348.